RLAY
Relay Therapeutics, Inc.
$13.42-1.53 (-10.23%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
Insider Activity
3 of 42 tradesExecutives investing their own money
🤖 AI InsightHaiku 4.5
Relay Therapeutics, Inc. (RLAY) is a publicly traded company with 5 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 1 unique insider. All recorded transactions were sales totaling $436K. Note that insider selling can occur for many reasons (diversification, tax planning, pre-scheduled 10b5-1 plans) and is not always a bearish signal. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 42 transactions (past 365 days)
| 2026-04-10 | 2026-04-09 | Catinazzo Thomas | CFO | Exercise Conversion | 1,800 | $0.00 | $0 |
| 2026-04-10 | 2026-04-09 | Catinazzo Thomas | CFO | Sale | 1,800 | $15.00 | $27,000 |
| 2026-04-10 | 2026-04-09 | Catinazzo Thomas | CFO | Exercise Conversion | 1,800 | $5.22 | $9,396 |
| 2026-04-10 | 2026-04-07 | Catinazzo Thomas | CFO | Sale | 17,717 | $13.01 | $230,498 |
| 2026-03-11 | 2026-03-09 | Catinazzo Thomas | CFO | Sale | 17,717 | $10.06 | $178,233 |
| 2026-01-15 | 2026-01-13 | Catinazzo Thomas | CFO | Award | 400,000 | $0.00 | $0 |
| 2026-01-15 | 2026-01-13 | Rahmer Peter | See Remarks | Award | 475,000 | $0.00 | $0 |
| 2026-01-15 | 2026-01-13 | Patel Sanjiv | CEO | Award | 1,450,000 | $0.00 | $0 |
| 2026-01-15 | 2026-01-13 | Bergstrom Donald A | President | Award | 575,000 | $0.00 | $0 |
| 2026-01-07 | 2026-01-06 | Patel Sanjiv | CEO | Sale | 43,168 | $7.82 | -$337,574 |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.